In the realm of targeted drug delivery and infusion care solutions, AIS Healthcare has distinguished itself as an industry leader. Celebrating fifteen years of dedicated service since its inception in 2008, AIS Healthcare has expanded its footprint, now operating in eight locations across six states and positively impacting the lives of more than 35,000 patients nationwide. Central to its success is a network of state-of-the-art compounding pharmacies staffed by highly trained pharmacists, committed to producing medications of the highest quality and sterility, ultimately leading to improved patient quality of life and better clinical outcomes.
For fifteen years, AIS Healthcare has consistently gone beyond the expected, delivering unparalleled care and support to patients. “Our commitment has always been to set higher quality standards for targeted drug delivery and infusion care, ultimately enhancing the lives of our patients,” says Simon Castellanos, AIS Healthcare’s Chief Executive Officer. As AIS Healthcare looks to the future, its mission remains unchanged: to continue improving the lives of both patients and physicians.
AIS Healthcare’s expertise shines through its cutting-edge 503A specialty pharmacies, where patient-specific prescriptions are compounded for its targeted drug delivery (TDD) division. These pharmacies provide personalized services tailored to meet the unique needs of patients and healthcare providers. Leveraging AIS Healthcare’s TDD medication and services, patients can more effectively manage chronic pain and spasticity, resulting in enhanced daily functionality and a better quality of life.
Beyond TDD, AIS Healthcare’s Advanced Infusion Care (AIC) division plays a crucial role in caring for patients with complex medical conditions, such as primary immunodeficiency. AIC employs a team-based approach to intravenous and subcutaneous immunoglobulin therapy patient care. With locations in Mississippi, Alabama, Georgia, Texas, Florida, and Maryland, AIC is poised to make a positive impact on patients’ lives.
AIS Healthcare’s commitment to excellence has earned it dual accreditation from URAC and the Accreditation Commission for Health Care (ACHC), setting it apart as an industry leader in targeted drug delivery and infusion care. As AIS Healthcare celebrates fifteen years, it remains steadfast in its mission to deliver transformative services across the care continuum.
In summary, AIS Healthcare’s fifteen-year journey is a testament to its unwavering commitment to quality and its relentless pursuit of improving patient lives. With innovative services and a dedication to excellence, AIS Healthcare continues to lead the way in revolutionizing healthcare delivery.